Assyro AI

FDA Orange Book · active-ingredient family

Chromic chloride

Chromic chloride is approved as 2 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

2

Brand (NDA)

1

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable

ProductApplicantApplicationTEApproved
CHROMIC CHLORIDE IN PLASTIC CONTAINERRLDHOSPIRANDA 018961APJun 26, 1986
CHROMIC CHLORIDEABRAXIS PHARMNDA 019271May 05, 1987

Generic (ANDA) products (1)

ProductApplicantApplicationTEApproved
CHROMIC CHLORIDESOMERSET THERAPS LLCANDA 218538APNov 18, 2024

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Chromic chloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.